Paying physicians to prescribe generic drugs and follow-on biologics in the United States

Ameet Sarpatwari; Niteesh K Choudhry; Jerry Avorn; Aaron S Kesselheim

doi:10.1371/journal.pmed.1001802

Paying physicians to prescribe generic drugs and follow-on biologics in the United States

PLoS Med. 2015 Mar 17;12(3):e1001802. doi: 10.1371/journal.pmed.1001802. eCollection 2015 Mar.

Authors

Ameet Sarpatwari¹, Niteesh K Choudhry¹, Jerry Avorn¹, Aaron S Kesselheim¹

Affiliation

¹ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.

Abstract

Aaron Kesselheim and colleagues examine potential strategies to promote greater prescribing of generic drugs and follow-on biologics.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Attitude of Health Personnel
Biological Products* / economics
Biological Products* / therapeutic use
Cost-Benefit Analysis
Drug Prescriptions* / economics
Drugs, Generic* / economics
Drugs, Generic* / therapeutic use
Health Care Costs*
Humans
Physicians*
Practice Patterns, Physicians'*
Salaries and Fringe Benefits*
Surveys and Questionnaires
United States

Substances

Biological Products
Drugs, Generic

Grant support

ASK’s work is supported by an Ignition Award from the Harvard Program in Therapeutic Science. ASK is a Greenwall Faculty Scholar in Bioethics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.